| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 委托加工服务(元) | 3,773,085.53 | 6,224,944.17 | 2,689,627.11 | 3,348,410.43 | - |
| 研发服务(元) | 178,066.05 | 649,866.05 | 167,949.06 | 752,967.86 | 245,771.68 |
| 药物中间体销售(元) | 60,126,799.36 | 92,194,974.86 | 30,907,946.73 | 54,481,299.85 | 31,319,457.34 |
| 会议服务(元) | - | 2,401.59 | - | - | - |
| 其他业务(元) | - | - | 1,510.50 | - | - |
| 营业成本(元) | |||||
| 委托加工服务(元) | 1,925,193.82 | 6,195,164.86 | 3,257,162.55 | 6,638,579.43 | - |
| 研发服务(元) | 73,323.42 | 316,276.18 | 82,400.65 | 355,540.29 | 207,485.09 |
| 药物中间体销售(元) | 44,850,862.17 | 88,748,607.55 | 30,045,750.50 | 53,329,926.59 | 29,108,464.33 |
| 会议服务(元) | - | - | - | - | - |
| 其他业务(元) | - | - | - | - | - |
| 毛利(元) | |||||
| 委托加工服务(元) | 1,847,891.71 | 29,779.31 | -567,535.44 | -3,290,169.00 | - |
| 研发服务(元) | 104,742.63 | 333,589.87 | 85,548.41 | 397,427.57 | 38,286.59 |
| 药物中间体销售(元) | 15,275,937.19 | 3,446,367.31 | 862,196.23 | 1,151,373.26 | 2,210,993.01 |
| 会议服务(元) | - | 2,401.59 | - | - | - |
| 其他业务(元) | - | - | 1,510.50 | - | - |
| 毛利率(%) | |||||
| 委托加工服务(%) | 48.98 | 0.48 | -21.10 | -98.26 | - |
| 研发服务(%) | 58.82 | 51.33 | 50.94 | 52.78 | 15.58 |
| 药物中间体销售(%) | 25.41 | 3.74 | 2.79 | 2.11 | 7.06 |
| 会议服务(%) | - | - | - | - | - |
| 其他业务(%) | - | - | - | - | - |
| 收入构成(%) | |||||
| 委托加工服务(%) | 5.89 | 6.28 | 7.97 | 5.72 | 0.00 |
| 研发服务(%) | 0.28 | 0.66 | 0.50 | 1.29 | 0.78 |
| 药物中间体销售(%) | 93.83 | 93.06 | 91.53 | 93.00 | 99.22 |
| 会议服务(%) | - | 0.00 | - | - | - |
| 其他业务(%) | - | - | 0.00 | - | - |
| 毛利构成(%) | |||||
| 委托加工服务(%) | 10.73 | 0.78 | -148.68 | - | 0.00 |
| 研发服务(%) | 0.61 | 8.75 | 22.41 | - | 1.70 |
| 药物中间体销售(%) | 88.67 | 90.41 | 225.87 | - | 98.30 |
| 会议服务(%) | - | 0.06 | - | - | - |
| 其他业务(%) | - | - | 0.40 | - | - |